Less overdiagnosis of kidney cancer? an age-period-cohort analysis of incidence trends in 16 populations worldwide

International Journal of Cancer

Volumn 141, Issue 5, 2017, Pages 925-932

  Znaor, Ariana ^a   Laversanne, Mathieu ^a   Bray, Freddie ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

age period cohort analysis; incidence trends; kidney cancer

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; BELARUS; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER REGISTRY; CHINA; COHORT ANALYSIS; COLOMBIA; COSTA RICA; CZECH REPUBLIC; DENMARK; DIAGNOSTIC ERROR; FEMALE; FINLAND; FRANCE; GEOGRAPHIC DISTRIBUTION; HUMAN; ITALY; JAPAN; KIDNEY CANCER; LITHUANIA; MAJOR CLINICAL STUDY; MALE; NORTH AMERICA; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX; SOUTH AMERICA; SPAIN; UNITED KINGDOM; UNITED STATES; VERY ELDERLY; HEALTH SERVICE; INCIDENCE; KIDNEY NEOPLASMS; MIDDLE AGED;

ADULT; AGED; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; KIDNEY NEOPLASMS; MALE; MEDICAL OVERUSE; MIDDLE AGED; PREVALENCE;

EID: 85020172242     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30799     Document Type: Article

References (39)

1. GLOBOCAN 2012. Version v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2014. Available from: URL: http://globocan.iarc.fr/Default.aspx. Accessed January 10, 2017.
2. Hollingsworth JM, Miller DC, Daignault S, et al. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 2006;98:1331–4.
3. Mindrup SR, Pierre JS, Dahmoush L, et al. The prevalence of renal cell carcinoma diagnosed at autopsy. BJU Int 2005;95:31–3.
4. Welch HG, Black WC, Overdiagnosis in cancer. J Natl Cancer Inst 2010;102:605–13.
5. Znaor A, Lortet-Tieulent J, Laversanne M, et al. International variations and trends in renal cell carcinoma incidence and mortality. Eur Urol 2015;67:519–30.
6. Nguyen MM, Gill IS, Ellison LM, The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program. J Urol 2006;176:2397–400.
7. Arnold M, Leitzmann M, Freisling H, et al. Obesity and cancer: An update of the global impact. Cancer Epidemiol 2016;41:8–15.
8. Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569–78.
9. Tobacco Smoking. A Review of Human Carcinogens: Personal Habits and Indoor Combustions. Lyon: International Agency for Research on Cancer, 2012.
10. Hunt JD, van der Hel OL, McMillan GP, et al. Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. Int J Cancer 2005;114:101–8.
11. Ebele JN, Sauter G, Epstein JI, et al. Pathology and genetics of tumours of the urinary system and male genital organs. Lyon, France: International Agency for Research on Cancer, 2004.
12. Moch H, Humphrey PA, Ulbright T, et al. WHO Classification of Tumours of the Urinary System and Male Genital Organs. Lyon: International Agency for Research on Cancer, 2016.
13. Scelo G, Hofmann JN, Banks RE, et al. International cancer seminars: a focus on kidney cancer. Ann Oncol 2016;27:1382–5.
14. Ferlay J, Parkin DM, Curado MP, et.al. Cancer incidence in five continents, volumes I to X: IARC CancerBase No. 9. International Agency for Research on Cancer, Lyon, France, 2010.
15. Doll R, Payne P, Waterhouse J. Cancer Incidence in Five Continents. Geneva, Switzerland: Union Internationale Contre le Cancer, 1966.
16. Clayton D, Schifflers E, Models for temporal variation in cancer rates. I: Age-period and age-cohort models. Stat Med 1987;6:449–67.
17. Clayton D, Schifflers E, Models for temporal variation in cancer rates. II: Age-period-cohort models. Stat Med 1987;6:469–81.
18. R Core Team. R: A language and environment for statistical computing. R. Foundation for Statistical Computing, Vienna, Austria 2016. Available from: URL: https://www.R-project.org/. Accessed September 29, 2016.
19. Scelo G, Brennan P, The epidemiology of bladder and kidney cancer. Nat Clin Pract Urol 2007;4:205–17.
20. Ondrusova M, Ondrus D, Muzik J, et al. Trends in the kidney cancer incidence and mortality in the Slovak and Czech Republics in 1980–2. Neoplasma 2011;58:165–71.
21. Tyson MD, Humphreys MR, Parker AS, et al. Age-period-cohort analysis of renal cell carcinoma in United States adults. Urology 2013;82:43–7.
22. Bao PP, Zheng Y, Wu CX, et al. Cancer incidence in urban Shanghai, 1973–2010: an updated trend and age-period-cohort effects. BMC Cancer 2016;16:284.
23. Chow WH, Dong LM, Devesa SS, Epidemiology and risk factors for kidney cancer. Nat Rev Urol 2010;7:245–57.
24. Marcos-Gragera R, Mallone S, Kiemeney LA, et al. Urinary tract cancer survival in Europe 1999–2007: Results of the population-based study EUROCARE-5. Eur J Cancer 2015.
25. Gandaglia G, Ravi P, Abdollah F, et al. Contemporary incidence and mortality rates of kidney cancer in the United States. Can Urol Assoc J 2014;8:247–52.
26. Smith-Bindman R, Miglioretti DL, Johnson E, et al. Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996–2010. JAMA 2012;307:2400–9.
27. Peto J, Gilham C, Fletcher O, et al. The cervical cancer epidemic that screening has prevented in the UK. Lancet 2004;364:249–56.
28. Vaccarella S, Lortet-Tieulent J, Plummer M, et al. Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors. Eur J Cancer 2013;49:3262–73.
29. Morgan DJ, Brownlee S, Leppin AL, et al. Setting a research agenda for medical overuse. BMJ 2015;351:h4534.
30. Brownlee S, Chalkidou K, Doust J, et al. Evidence for overuse of medical services around the world. Lancet 2017.
31. Esserman LJ, Thompson IM, Reid B, et al. Addressing overdiagnosis and overtreatment in cancer: a prescription for change. Lancet Oncol 2014;15(6):e234–e242.
32. Fritz A, Percy C, Jack A, et al. World Health Organization. International classification of diseases for oncology, 3rd ed ed. Geneva: World Health Organization, 2000.
33. Epstein JI, Amin MB, Reuter VR, et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998;22:1435–48.
34. Williamson SR, Cheng L, Clear cell renal cell tumors: Not all that is “clear” is cancer. Urol Oncol 2016;34:292–22.
35. Srigley JR, Delahunt B, Eble JN, et al. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am J Surg Pathol 2013;37:1469–89.
36. Sun M, Abdollah F, Bianchi M, et al. Treatment management of small renal masses in the 21st century: a paradigm shift. Ann Surg Oncol 2012;19:2380–7.
37. Rini BI, Campbell SC, Escudier B, Renal cell carcinoma. Lancet 2009;373:1119–32.
38. Capitanio U, Montorsi F, Renal cancer. Lancet 2016;387:894–906.
39. Preventing Overdiagnosis Board. Preventing overdiagnosis. Available from: URL: http://www.preventingoverdiagnosis.net/Accessed January 10, 2017.